Clinical features and molecular epidemiology of diarrheagenic Escherichia coli pathotypes identified by fecal gastrointestinal multiplex nucleic acid amplification in patients with cancer and diarrhea

Diagnostic Microbiology and Infectious Disease

Volumn 89, Issue 3, 2017, Pages 235-240

  Chao, Andrew W ^a,b   Bhatti, Micah ^a   DuPont, Herbert L ^b,c   Nataro, James P ^d   Carlin, Lily G ^a   Okhuysen, Pablo C ^a,b,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Biofire FilmArray; Cancer; Diarrhea; Diarrheagenic E. coli; Enteroaggregative E. coli; Enteropathogenic E. coli; Gastrointestinal pathogens

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE; QUINOLONE DERIVATIVE; VIRULENCE FACTOR; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL SHEDDING; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CANCER CHEMOTHERAPY; CHILD; CLINICAL FEATURE; DIARRHEA; DIARRHEAGENIC ESCHERICHIA COLI; ENTEROAGGREGATIVE ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FECES ANALYSIS; FEMALE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; MOLECULAR EPIDEMIOLOGY; NEUTROPENIA; NONHUMAN; NOROVIRUS; NUCLEIC ACID AMPLIFICATION; PATHOTYPE; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RECURRENT DISEASE; RISK FACTOR; SEASONAL VARIATION; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; TRAVEL; UNITED STATES; COMPLICATION; DRUG EFFECT; ESCHERICHIA COLI; FECES; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; NEOPLASM; REAL TIME POLYMERASE CHAIN REACTION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; DIARRHEA; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; NEOPLASMS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REAL-TIME POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 85029476224     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2017.08.004     Document Type: Article

References (48)

1. Adachi, J.A., Ericsson, C.D., Jiang, Z.D., DuPont, M.W., Pallegar, S.R., DuPont, H.L., Natural history of enteroaggregative and enterotoxigenic Escherichia coli infection among US travelers to Guadalajara, Mexico. J Infect Dis 185:11 (2002), 1681–1683.
2. Arenas-Hernandez, M.M., Martinez-Laguna, Y., Torres, A.G., Clinical implications of enteroadherent Escherichia coli. Curr Gastroenterol Rep 14:5 (2012), 386–394.
3. Barletta, F., Ochoa, T.J., Mercado, E., Ruiz, J., Ecker, L., Lopez, G., et al. Quantitative real-time polymerase chain reaction for enteropathogenic Escherichia coli: a tool for investigation of asymptomatic versus symptomatic infections. Clin Infect Dis 53:12 (2011), 1223–1229.
4. de Blank, P., Zaoutis, T., Fisher, B., Troxel, A., Kim, J., Aplenc, R., Trends in Clostridium difficile infection and risk factors for hospital acquisition of Clostridium difficile among children with cancer. J Pediatr 163:3 (2013), 699–705 [e1].
5. Boisen, N., Ruiz-Perez, F., Scheutz, F., Krogfelt, K.A., Nataro, J.P., Short report: high prevalence of serine protease autotransporter cytotoxins among strains of enteroaggregative Escherichia coli. Am J Trop Med Hyg 80:2 (2009), 294–301.
6. Buss, S.N., Leber, A., Chapin, K., Fey, P.D., Bankowski, M.J., Jones, M.K., et al. Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis. J Clin Microbiol 53:3 (2015), 915–925.
7. Cherny, N.I., Evaluation and management of treatment-related diarrhea in patients with advanced cancer: a review. J Pain Symptom Manage 36:4 (2008), 413–423.
8. Chopra, T., Alangaden, G.J., Chandrasekar, P., Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients. Expert Rev Anti Infect Ther 8:10 (2010), 1113–1119.
9. Clausen, C.R., Christie, D.L., Chronic diarrhea in infants caused by adherent enteropathogenic Escherichia coli. J Pediatr 100:3 (1982), 358–361.
10. Cohen, M.B., Nataro, J.P., Bernstein, D.I., Hawkins, J., Roberts, N., Staat, M.A., Prevalence of diarrheagenic Escherichia coli in acute childhood enteritis: a prospective controlled study. J Pediatr 146:1 (2005), 54–61.
11. Dupont, H.L., Jiang, Z.D., Belkind-Gerson, J., Okhuysen, P.C., Ericsson, C.D., Ke, S., et al. Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone. Clin Gastroenterol Hepatol 5:4 (2007), 451–456.
12. Enserink, R., Scholts, R., Bruijning-Verhagen, P., Duizer, E., Vennema, H., de Boer, R., et al. High detection rates of enteropathogens in asymptomatic children attending day care. PLoS One, 9(2), 2014, e89496.
13. Frank, C., Werber, D., Cramer, J.P., Askar, M., Faber, M., an der Heiden, M., et al. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med 365:19 (2011), 1771–1780.
14. Garcia, P.G., Silva, V.L., Diniz, C.G., Occurrence and antimicrobial drug susceptibility patterns of commensal and diarrheagenic Escherichia coli in fecal microbiota from children with and without acute diarrhea. J Microbiol 49:1 (2011), 46–52.
15. Gu, Z., Zhu, H., Rodriguez, A., Mhaissen, M., Schultz-Cherry, S., Adderson, E., et al. Comparative evaluation of broad-panel PCR assays for the detection of gastrointestinal pathogens in pediatric oncology patients. J Mol Diagn 17:6 (2015), 715–721.
16. Hao, R., Qiu, S., Wang, Y., Yang, G., Su, W., Song, L., et al. Quinolone-resistant Escherichia coli O127a:K63 serotype with an extended-spectrum-beta-lactamase phenotype from a food poisoning outbreak in China. J Clin Microbiol 50:7 (2012), 2450–2451.
17. Harris, L., Farber, J., Beuchat, L., Parrish, M., Suslow, E., Garret, E., et al. Outbreaks associated with fresh produce: incidence, growth, and survival of pathogens in fresh and fresh cut produce. Compr Rev Food Sci Food Saf 2 (2003), 78–141 (Supplement).
18. Harris, P.A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., Conde, J.G., Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42:2 (2009), 377–381.
19. Hedberg, C.W., Savarino, S.J., Besser, J.M., Paulus, C.J., Thelen, V.M., Myers, L.J., et al. An outbreak of foodborne illness caused by Escherichia coli O39:NM, an agent not fitting into the existing scheme for classifying diarrheogenic E. coli. J Infect Dis 176:6 (1997), 1625–1628.
20. Herzog, K., Engeler Dusel, J., Hugentobler, M., Beutin, L., Sagesser, G., Stephan, R., et al. Diarrheagenic enteroaggregative Escherichia coli causing urinary tract infection and bacteremia leading to sepsis. Infection 42:2 (2014), 441–444.
21. Jensen, C., Ethelberg, S., Olesen, B., Schiellerup, P., Olsen, K.E., Scheutz, F., et al. Attaching and effacing Escherichia coli isolates from Danish children: clinical significance and microbiological characteristics. Clin Microbiol Infect 13:9 (2007), 863–872.
22. Kim, J.S., Ward, K.K., Shah, N.R., Saenz, C.C., McHale, M.T., Plaxe, S.C., Excess risk of Clostridium difficile infection in ovarian cancer is related to exposure to broad-spectrum antibiotics. Support Care Cancer 21:11 (2013), 3103–3107.
23. Kotloff, K.L., Blackwelder, W.C., Nasrin, D., Nataro, J.P., Farag, T.H., van Eijk, A., et al. The global enteric multicenter study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study. Clin Infect Dis 55:Suppl. 4 (2012), S232–45.
24. Lindsay, B., Ochieng, J.B., Ikumapayi, U.N., Toure, A., Ahmed, D., Li, S., et al. Quantitative PCR for detection of Shigella improves ascertainment of Shigella burden in children with moderate-to-severe diarrhea in low-income countries. J Clin Microbiol 51:6 (2013), 1740–1746.
25. Liu, J., Platts-Mills, J.A., Juma, J., Kabir, F., Nkeze, J., Okoi, C., et al. Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study. Lancet 388:10051 (2016), 1291–1301.
26. Luna-Gierke, R.E., Griffin, P.M., Gould, L.H., Herman, K., Bopp, C.A., Strockbine, N., et al. Outbreaks of non-O157 Shiga toxin-producing Escherichia coli infection: USA. Epidemiol Infect, 2014, 1–11.
27. Mohamed, J.A., Huang, D.B., Jiang, Z.D., DuPont, H.L., Nataro, J.P., Belkind-Gerson, J., et al. Association of putative enteroaggregative Escherichia coli virulence genes and biofilm production in isolates from travelers to developing countries. J Clin Microbiol 45:1 (2007), 121–126.
28. Moreira, C.G., Palmer, K., Whiteley, M., Sircili, M.P., Trabulsi, L.R., Castro, A.F., et al. Bundle-forming pili and EspA are involved in biofilm formation by enteropathogenic Escherichia coli. J Bacteriol 188:11 (2006), 3952–3961.
29. Mortensen, N.P., Boisen, N., Carey, S., Kennel, S.J., Fowlkes, J.D., Doktycz, M.J., et al. Enteroaggregative Escherichia coli: surface protein dispersin increases bacterial uptake of ciprofloxacin. Int J Antimicrob Agents 42:5 (2013), 462–465.
30. Mwachari, C., Batchelor, B.I., Paul, J., Waiyaki, P.G., Gilks, C.F., Chronic diarrhoea among HIV-infected adult patients in Nairobi. Kenya J Infect 37:1 (1998), 48–53.
31. Nataro, J.P., Kaper, J.B., Diarrheagenic Escherichia coli. Clin Microbiol Rev 11:1 (1998), 142–201.
32. Nataro, J.P., Mai, V., Johnson, J., Blackwelder, W.C., Heimer, R., Tirrell, S., et al. Diarrheagenic Escherichia coli infection in Baltimore, Maryland, and new haven, Connecticut. Clin Infect Dis 43:4 (2006), 402–407.
33. Ochoa, T.J., Ecker, L., Barletta, F., Mispireta, M.L., Gil, A.I., Contreras, C., et al. Age-related susceptibility to infection with diarrheagenic Escherichia coli among infants from Periurban areas in lima, Peru. Clin Infect Dis 49:11 (2009), 1694–1702.
34. Paredes-Paredes, M., Okhuysen, P.C., Flores, J., Mohamed, J.A., Padda, R.S., Gonzalez-Estrada, A., et al. Seasonality of diarrheagenic Escherichia coli pathotypes in the US students acquiring diarrhea in Mexico. J Travel Med 18:2 (2011), 121–125.
35. Pitt, J.M., Vetizou, M., Waldschmitt, N., Kroemer, G., Chamaillard, M., Boneca, I.G., et al. Fine-tuning cancer immunotherapy: optimizing the gut microbiome. Cancer Res 76:16 (2016), 4602–4607.
36. Pop, M., Walker, A.W., Paulson, J., Lindsay, B., Antonio, M., Hossain, M.A., et al. Diarrhea in young children from low-income countries leads to large-scale alterations in intestinal microbiota composition. Genome Biol, 15(6), 2014, R76.
37. Rand, K.H., Tremblay, E.E., Hoidal, M., Fisher, L.B., Grau, K.R., Karst, S.M., Multiplex gastrointestinal pathogen panels: implications for infection control. Diagn Microbiol Infect Dis 82:2 (2015), 154–157.
38. Seekatz, A.M., Rao, K., Santhosh, K., Young, V.B., Dynamics of the fecal microbiome in patients with recurrent and nonrecurrent Clostridium difficile infection. Genome Med, 8(1), 2016, 47.
39. Shaw, C., Taylor, L., Treatment-related diarrhea in patients with cancer. Clin J Oncol Nurs 16:4 (2012), 413–417.
40. Spina, A., Kerr, K.G., Cormican, M., Barbut, F., Eigentler, A., Zerva, L., et al. Spectrum of enteropathogens detected by the FilmArray GI panel in a multicentre study of community-acquired gastroenteritis. Clin Microbiol Infect 21:8 (2015), 719–728.
41. Steffen, R., Hill, D.R., DuPont, H.L., Traveler's diarrhea: a clinical review. JAMA 313:1 (2015), 71–80.
42. Steiner, T.S., Lima, A.A., Nataro, J.P., Guerrant, R.L., Enteroaggregative Escherichia coli produce intestinal inflammation and growth impairment and cause interleukin-8 release from intestinal epithelial cells. J Infect Dis 177:1 (1998), 88–96.
43. Stockmann, C., Rogatcheva, M., Harrel, B., Vaughn, M., Crisp, R., Poritz, M., et al. How well does physician selection of microbiologic tests identify Clostridium difficile and other pathogens in paediatric diarrhoea? Insights using multiplex PCR-based detection. Clin Microbiol Infect, 21(2), 2015 [179 e9-15].
44. Sullivan, P.B., Coles, M.A., Aberra, G., Ljungh, A., Enteropathogenic and enteroadherent-aggregative Escherichia coli in children with persistent diarrhoea and malnutrition. Ann Trop Paediatr 14:2 (1994), 105–110.
45. Taur, Y., Xavier, J.B., Lipuma, L., Ubeda, C., Goldberg, J., Gobourne, A., et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 55:7 (2012), 905–914.
46. Taur, Y., Jenq, R.R., Ubeda, C., van den Brink, M., Pamer, E.G., Role of intestinal microbiota in transplantation outcomes. Best Pract Res Clin Haematol 28:2–3 (2015), 155–161.
47. Vijay, D., Dhaka, P., Vergis, J., Negi, M., Mohan, V., Kumar, M., et al. Characterization and biofilm forming ability of diarrhoeagenic enteroaggregative Escherichia coli isolates recovered from human infants and young animals. Comp Immunol Microbiol Infect Dis 38 (2015), 21–31.
48. Wasteson, Y., Zoonotic Escherichia coli. Acta Vet Scand Suppl 95 (2001), 79–84.